Tech Company Financing Transactions
Mediar Therapeutics Funding Round
On 3/18/2021, Mediar Therapeutics raised Seed funding from Ono Venture Investment and Pfizer Venture Investments.
Transaction Overview
Company Name
Announced On
3/18/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Ono Venture Investment (Hiroshi Yamamoto)
Pfizer Venture Investments (Nikola Trbovic)
Proceeds Purpose
The funding will support development of the firm's unique myofibroblast discovery platform and will advance the company's development of antibody treatments against a suite of novel targets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St.
North Cambridge, MA 02139
USA
North Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Mediar is a discovery stage biotechnology company developing treatments to halt, or even reverse, fibrosis. Our platform and pipeline are based on an emerging class of novel targets -- fibrotic mediators -- that play key roles in modulating myofibroblasts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meredith Fisher
Chief Scientific Officer
Paul Yaworsky
Browse more venture capital transactions:
Prev: 3/18/2021: Happify venture capital transaction
Next: 3/18/2021: 75F venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs